This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through November 3, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
COR Q4 Earnings & Revenues Beat Estimates, Gross Margin Improves
by Zacks Equity Research
Cencora's Q4 results top estimates with 15% EPS growth and stronger margins, as GLP-1 demand and the RCA acquisition fuel solid segment gains.
BSXPositive Net Change ALCPositive Net Change CORPositive Net Change SOLVPositive Net Change
earnings medical medical-devices
FMS Stock Rises as Q3 Earnings Beat Estimates, Revenues Gain Y/Y
by Zacks Equity Research
Fresenius Medical Care's Q3 earnings and revenues beat estimates, fueled by margin gains and solid organic growth across segments.
BSXPositive Net Change ALCPositive Net Change FMSPositive Net Change SOLVPositive Net Change
earnings medical medical-devices
CRL's Q3 Earnings Top Estimates, Revenues Decline Y/Y, Stock Falls
by Zacks Equity Research
Charles River beats Q3 profit and revenue forecasts but posts year-over-year declines and narrows its 2025 outlook.
BSXPositive Net Change ISRGNegative Net Change CRLNegative Net Change MEDPNegative Net Change
earnings medical medical-devices
Boston Scientific Sustains EP Momentum in Q3: Is More Upside Ahead?
by Moumi Mondal
BSX's Q3 EP sales soar 63% on FARAPULSE momentum, FDA label expansion and rising global adoption.
ABTPositive Net Change BSXPositive Net Change MDTPositive Net Change
medical medical-devices
Are Options Traders Betting on a Big Move in Alphatec Stock?
by Zacks Equity Research
Investors need to pay close attention to ATEC stock based on the movements in the options market lately.
ATECPositive Net Change
medical-devices
Can Aveanna Drive a Strong Third Quarter on Care-Delivery Momentum?
by Zacks Equity Research
AVAH's solid care-hour growth, stronger reimbursement rates and margin gains are likely to set the stage for another robust quarter.
ADUSPositive Net Change AVAHNegative Net Change EHABPositive Net Change BTSGPositive Net Change
medical medical-devices
INSP Stock Gains Following Q3 Earnings Beat, Gross Margin Expands
by Zacks Equity Research
Inspire Medical tops third-quarter 2025 estimates as revenue climbs and gross margin improves, with full-year EPS guidance raised.
BSXPositive Net Change HCAPositive Net Change WSTNegative Net Change INSPNegative Net Change
earnings medical medical-devices
DENTSPLY SIRONA to Post Q3 Earnings: What's in Store for the Stock?
by Zacks Equity Research
Dentsply Sirona's Q3 results may reveal ongoing softness in U.S. demand and orthodontic segments despite steady cost control.
XRAYNegative Net Change CORPositive Net Change GMEDNegative Net Change SOLVPositive Net Change
medical medical-devices
Solventum to Post Q3 Earnings: Is a Beat Likely for the Stock?
by Zacks Equity Research
Solventum's Q3 results may reflect softer sales and tariff impacts, though pricing discipline and core growth drivers likely aided margins.
MCKNegative Net Change CORPositive Net Change GMEDNegative Net Change SOLVPositive Net Change
medical medical-devices
Will Strong Segmental Performance Drive MCK's Top Line in Q2?
by Zacks Equity Research
McKesson's Q2 results may show steadier growth as strong U.S. pharmaceutical and RxTS momentum drive its expanding top line.
MCKNegative Net Change CORPositive Net Change GMEDNegative Net Change SOLVPositive Net Change
medical medical-devices
HOLX Stock Up on Q4 Earnings & Revenue Beat, Operating Margin Expands
by Zacks Equity Research
Hologic posts solid Q4 gains with earnings and revenue beat, margin expansion, and a buyout deal by Blackstone and TPG.
BSXPositive Net Change ISRGNegative Net Change HOLXPositive Net Change MEDPNegative Net Change
earnings medical medical-devices
Can TerrAscend Deliver a Solid Q3 on Core Market Strength Ahead?
by Zacks Equity Research
TSNDF's Q3 results are likely to benefit from Northeast market strength, margin gains, and a streamlined focus following its Michigan exit.
ACBPositive Net Change GTBIFPositive Net Change CURLFPositive Net Change TSNDFPositive Net Change
medical medical-devices
Can Strength in Rental Business Drive INFU Stock Before Q3 Earnings?
by Zacks Equity Research
InfuSystem eyes third-quarter 2025 gains as rental contracts and ERP upgrades boost margins across Patient Services and Device Solutions.
PODDPositive Net Change LMATPositive Net Change PAHCNegative Net Change INFUPositive Net Change
earnings medical medical-devices
Can Sustained Product Demand Drive BDX Stock Before Q4 Earnings?
by Zacks Equity Research
BD rides high on product demand across segments, but fourth-quarter fiscal 2025 results may face pressure from global market dynamics.
BDXPositive Net Change CNMDPositive Net Change MCKNegative Net Change COONegative Net Change
earnings medical medical-devices
Take the Zacks Approach to Beat the Markets: Siemens, UiPath & Caterpillar in Focus
by Santanu Roy
Zacks' time-tested strategies spotlight Siemens, UiPath and Caterpillar as standout gainers amid shifting market dynamics.
CATNegative Net Change JNJPositive Net Change PEPPositive Net Change HIIPositive Net Change CORPositive Net Change PATHNegative Net Change MTDNegative Net Change STRLNegative Net Change MTZNegative Net Change NOBLPositive Net Change SMNEYNegative Net Change LGRDYNegative Net Change
aerospace alt-energy computers construction consumer-staples industrial-products medical medical-devices pharmaceuticals
CVS' Health Care Delivery Arm Likely to See Better Financial Results
by Moumi Mondal
CVS Health's scaled-back Oak Street expansion, clinic closures and tech investments aim to drive stronger Health Care Delivery results next year.
UNHPositive Net Change CIPositive Net Change CVSNegative Net Change
medical medical-devices
Can Specialty and GLP-1 Momentum Support Cencora's Q4 Results?
by Zacks Equity Research
Cencora's Q4 results may reflect solid U.S. specialty and GLP-1 momentum, tempered by slower growth and international softness.
MCKNegative Net Change CORPositive Net Change GMEDNegative Net Change SOLVPositive Net Change
medical medical-devices
3 MedTech Stocks Positioned to Surpass Q3 Earnings Estimates
by Indrajit Bandyopadhyay
Despite tariff and inflation pressures, innovation-fueled momentum in diabetes care, surgical tech, and cardiovascular devices could drive upside surprises for SOLV, COR and INSP this earnings season.
CORPositive Net Change INSPNegative Net Change SOLVPositive Net Change
medical medical-devices
Merit Medical Q3 Earnings & Revenues Beat Estimate, Margins Expand
by Zacks Equity Research
MMSI beats third-quarter 2025 estimates on strong revenue and margin growth, prompting a raised full-year outlook across segments.
BSXPositive Net Change ISRGNegative Net Change MMSIPositive Net Change GEHCNegative Net Change
earnings medical medical-devices
Hims & Hers Scales AI-Driven Personalized Health and Wellness
by Debanjana Dey
HIMS scales AI-driven care with new hormonal health lines, global expansion plans and a $870 million funding boost.
MEDPositive Net Change GDRXPositive Net Change HIMSNegative Net Change
medical medical-devices
DexCom Stock Falls Despite Q3 Earnings Beat, 2025 Revenue View Raised
by Zacks Equity Research
DXCM posts double-digit Q3 growth and raises 2025 revenue outlook, but shares tumble despite strong CGM momentum and innovation updates.
BSXPositive Net Change DXCMNegative Net Change HQYNegative Net Change SOLVPositive Net Change
earnings medical medical-devices
Demographic Megatrend: Stocks Poised to Benefit From Global Aging
by Urmimala Biswas
Global aging is reshaping healthcare demand. Discover how AbbVie, Amgen, Boston Scientific and Edwards are positioned to gain from this powerful megatrend.
BSXPositive Net Change AMGNPositive Net Change EWNegative Net Change OHIPositive Net Change ABBVNegative Net Change CTREPositive Net Change ENSGPositive Net Change
biotechs cell-therapy gene-therapy genetics genomics healthcare hospitals medical medical-devices
4 Resilient Dental Supply Players Positioned to Withstand Tariff Risks
by Indrajit Bandyopadhyay
Here, we discuss four stocks from the Dental Supplies industry that are likely to generate wealth for investors amid tariff uncertainty. These are MCK, CAH, WST and COO.
MCKNegative Net Change CAHNegative Net Change COONegative Net Change WSTNegative Net Change
medical medical-devices
SYK Stock Falls Despite Q3 Earnings & Sales Beat, '25 View Up
by Zacks Equity Research
Stryker's Q3 results top estimates with double-digit sales and profit growth, but shares slip as investors weigh tariff pressures despite an upbeat 2025 outlook.
BSXPositive Net Change SYKPositive Net Change GEHCNegative Net Change SOLVPositive Net Change
earnings medical medical-devices
Prescription for Beats: 3 Healthcare Stocks Set to Outperform in Q3
by Kaibalya Pravo Dey
Humana, Cencora and Globus Medical are poised to outshine in the September quarter, driven by strong demand, innovation and volume growth.
HUMPositive Net Change CORPositive Net Change GMEDNegative Net Change
biotechnology earnings insurance medical medical-devices pharmaceuticals